Cargando…

Significant clinical response of advanced colorectal cancer to combination therapy involving capecitabine and adoptive cell transfer therapy: a case report

Significant clinical response was obtained in a patient with stage IV colorectal cancer (CRC) following combination therapy involving capecitabine and adoptive cell transfer therapy. She had laparoscopic lower anterior resection and left liver metastatic carcinoma resecting in 20th, February, 2017....

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Shuchun, Ma, Junjun, Hong, Xizhou, Zheng, Minhua, Goto, Shigenori, Takimoto, Rishu, Kamigaki, Takashi, Zang, Lu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2019
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798970/ https://www.ncbi.nlm.nih.gov/pubmed/35116802 http://dx.doi.org/10.21037/tcr.2019.02.06

Ejemplares similares

Esophageal cancer responsive to the combination of immune cell therapy and low-dose nivolumab: two case reports
por: Takimoto, Rishu, et al.
Publicado: (2021)

Effects of adaptive immune cell therapy on the immune cell profile in patients with advanced gastric cancer
por: Miura, Miyabi, et al.
Publicado: (2020)

Comprehensive immunotherapy combined with intratumoral injection of zoledronate-pulsed dendritic cells, intravenous adoptive activated T lymphocyte and gemcitabine in unresectable locally advanced pancreatic carcinoma: a phase I/II trial
por: Hirooka, Yoshiki, et al.
Publicado: (2017)

ACACB is a novel metabolism-related biomarker in the prediction of response to cetuximab therapy inmetastatic colorectal cancer: ACACB is a biomarker for CTX therapy in metastatic CRC
por: Hong, Hi-Ju, et al.
Publicado: (2022)

Self-Reported Adherence to Capecitabine on XELOX Treatment as Adjuvant Therapy for Colorectal Cancer
por: Kawakami, Kazuyoshi, et al.
Publicado: (2017)

Zoledronate-pulsed dendritic cell-based anticancer vaccines
por: Kamigaki, Takashi, et al.
Publicado: (2013)

Chemo-immune cell therapy by intratumoral injection of adoptive NK cells with capecitabine in gastric cancer xenograft model
por: Ghazvinian, Zeinab, et al.
Publicado: (2023)

Exploring the role of pyroptosis in shaping the tumor microenvironment of colorectal cancer by bulk and single-cell RNA sequencing
por: Ding, Chengsheng, et al.
Publicado: (2023)

Extended survival observed in adoptive activated T lymphocyte immunotherapy for advanced lung cancer: results of a multicenter historical cohort study
por: Iwai, Kazuro, et al.
Publicado: (2012)

Capecitabine in the management of colorectal cancer
por: Hirsch, Bradford R, et al.
Publicado: (2011)

GJA1 is a Prognostic Biomarker and Correlated with Immune Infiltrates in Colorectal Cancer
por: Hu, Wenjun, et al.
Publicado: (2020)

IDO in Colorectal Tumorigenesis: Involvement of Immune Tolerance and Significance in Prevention and Therapy
por: Tang, Shunan, et al.
Publicado: (2021)

Capecitabine and mitomycin C as third-line therapy for patients with metastatic colorectal cancer resistant to fluorouracil and irinotecan
por: Chong, G, et al.
Publicado: (2005)

Combining gut microbiota modulation and chemotherapy by capecitabine-loaded prebiotic nanoparticle improves colorectal cancer therapy
por: Lang, Tianqun, et al.
Publicado: (2023)

Association of Single-Nucleotide Polymorphisms in Capecitabine Bioactivation Pathway with Adjuvant Therapy Safety in Colorectal Cancer Patients
por: Cura, Yasmin, et al.
Publicado: (2023)

Immune cell labelling and tracking: implications for adoptive cell transfer therapies
por: Galli, Filippo, et al.
Publicado: (2021)

Gene editing: Towards the third generation of adoptive T-cell transfer therapies
por: Puig-Saus, Cristina, et al.
Publicado: (2019)

Adoptive Transfer of Photosensitizer-Loaded Cytotoxic T Cells for Combinational Photodynamic Therapy and Cancer Immuno-Therapy
por: Blaudszun, André-René, et al.
Publicado: (2023)

Identification of key genes and pathways involved in microsatellite instability in colorectal cancer
por: Yu, Chaoran, et al.
Publicado: (2019)

Microsatellite Status Affects Tumor Response and Survival in Patients Undergoing Neoadjuvant Chemotherapy for Clinical Stage III Gastric Cancer
por: Cai, Zhenghao, et al.
Publicado: (2020)

Adoptive Cell Transfer: Is it a Promising Immunotherapy for Colorectal Cancer?
por: Fan, Jiaqiao, et al.
Publicado: (2018)

Clinical application of adoptive T cell therapy in solid tumors
por: Zang, Yi-Wen, et al.
Publicado: (2014)

Concurrent capecitabine and upper abdominal radiation therapy is well tolerated
por: Das, Prajnan, et al.
Publicado: (2006)

Capecitabine maintenance therapy in patients with recurrent or metastatic breast cancer
por: Si, W., et al.
Publicado: (2013)

Concomitant (177)Lu-DOTATATE and capecitabine therapy in malignant paragangliomas
por: Yadav, Madhav Prasad, et al.
Publicado: (2019)

Spontaneous coronary artery dissection during cisplatin and capecitabine therapy
por: Somov, Pavel, et al.
Publicado: (2019)

Capecitabine Plus Oxaliplatin Combination Therapy for Basal Cell Carcinoma
por: Rhee, Jiyoung, et al.
Publicado: (2019)

Differential Involvement of Autophagy and Apoptosis in Response to Chemoendocrine and Endocrine Therapy in Breast Cancer: JBCRG-07TR
por: Ueno, Takayuki, et al.
Publicado: (2019)

Allogeneic adoptive cell transfer therapy as a potent universal treatment for cancer
por: Marcus, Assaf, et al.
Publicado: (2011)

A New Hope in Immunotherapy for Malignant Gliomas: Adoptive T Cell Transfer Therapy
por: Chung, Dong-Sup, et al.
Publicado: (2014)

Generation of TCRα-transduced T cells for adoptive transfer therapy of salmonellosis in mice
por: Kalinina, Anastasiia, et al.
Publicado: (2021)

Toxicity associated with capecitabine plus oxaliplatin in colorectal cancer before and after an institutional policy of capecitabine dose reduction
por: Baird, R, et al.
Publicado: (2011)

Adoptive T-Cell Therapy in Advanced Colorectal Cancer: A Systematic Review
por: Juat, Damie J, et al.
Publicado: (2022)

Advances in adoptive cellular therapy for colorectal cancer: a narrative review
por: Yi, Xing, et al.
Publicado: (2022)

A review of the role of capecitabine in the treatment of colorectal cancer
por: Comella, Pasquale
Publicado: (2007)

First-line chemotherapy with docetaxel plus capecitabine followed by capecitabine or hormone maintenance therapy for the treatment of metastatic breast cancer patients
por: LIANG, XU, et al.
Publicado: (2015)

Two doses of NGR-hTNF in combination with capecitabine plus oxaliplatin in colorectal cancer patients failing standard therapies
por: Mammoliti, S., et al.
Publicado: (2011)

A greater lymph node yield is required during pathological examination in microsatellite instability-high gastric cancer
por: Cai, Zhenghao, et al.
Publicado: (2021)

Adoptive transfer of TILs plus anti-PD1 therapy: An alternative combination therapy for treating metastatic osteosarcoma
por: Wang, Chao, et al.
Publicado: (2020)

BRAF inhibition improves tumor recognition by the immune system: Potential implications for combinatorial therapies against melanoma involving adoptive T-cell transfer
por: Donia, Marco, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_lhbn4392jbiqq0e5kdpfv0ccrh